Association of dyslipidemia in second trimester of pregnancy with preeclampsia

Kanmani K., Sudha Subramanian


Background: The study aimed to determine whether dyslipidemia in the second trimester of pregnancy is associated with pre-eclampsia and to investigate and compare the levels of serum lipids among preeclampsia and normal pregnant women.

Methods: This prospective cohort study was done between March 2016 to February 2017. Fasting lipid profile was taken for about 200 selected antenatal women between 18-20 weeks of gestation. The patients who developed pre-eclampsia were grouped as preeclampsia group and the rest of the patients were grouped as normal group. The maternal characteristics compared between two groups were age, parity, BMI and socioeconomic class according to modified Kuppuswamy scale.

Results: There is statistical significance among the two groups with respect to BMI and parity whereas no significance with age distribution. Mean total cholesterol in Preeclampsia was 240.24±46.63 mg/dl and normal pregnancy was 186.10±28.02 mg/dl. Mean HDL in preeclampsia was 47.49±4.40mg/dl and normal pregnancy was 52.11±8.918 mg/dl. Mean LDL in preeclampsia was 140.43±36.92 mg/ dl and normal pregnancy was 94.6±24.5 mg/dl. Mean VLDL in preeclampsia was 64.48±15.76mg/dl and in normal pregnancy was 33.54±9.38 mg/dl, Mean Triglycerides in preeclampsia was 291.95±82.33 mg/dl and normal pregnancy was 166.78±48.83 mg/dl. Total cholesterol, Low density lipoprotein, very low-density lipoprotein, triglycerides were increased in preeclampsia when compared to normal pregnancy, which is statistically significant.

Conclusions: Detecting dyslipidemia before 20 weeks of gestation helps to recognise pregnancies at high risk for preeclampsia and to detect and treat the disease earlier for a better maternal and perinatal outcome.


Preeclampsia, Triglycerides, Total cholesterol

Full Text:



Repke JT, Robinson JN. The prevention and management of pre-eclampsia and eclampsia. Int J Gynaecol Obstet. 1998;62:1-9.

Sharma JB, Sharma A, Bahadur A, Vimala N, Satyam A, Mittal, S. Oxidative stressmarkers and antioxidant levels in normal pregnancy and pre-eclampsia. Int J Gynaecol Obstet. 2006;94:23-7.

Berg CJ, Chang J, Callaghan Wm, et al. Pregnancy related mortality in united states 1991-1997. Obstet Gynecol. 2003;101:289.

Wiznitzer A, Mayer A, Novack V, Sheiner E, Gilutz H, Malhotra A, et al. Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: A population-based study. Am J Obstet Gynecol. 2009;201:482.e1-e8.

El-Mazny A, Abou-Salem N, El-Sherbiny W, El-Mazny A. Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2010;109:239-41.

Mankuta D, Elami-Suzin M, Elhayani A, Vinker S. Lipid profile in consecutive pregnancies. Lipids Health Dis. 2010;9:58.

Llurba E, Casals E, Domínguez C, Delgado J, Mercadé I, Crispi F, et al. Atherogenic lipoprotein subfraction profile in preeclamptic women with and without high triglycerides: Different pathophysiologic subsets in preeclampsia. Metabolism. 2005;54:1504-9.

Roberts JM, Gammill H. Insulin resistance in preeclampsia. Hypertension. 2006;47:341-2.

Catov JM, Bodnar LM, Kip KE, Hubel C, Ness RB, Harger G, et al. Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol. 2007;197:610.e1-e7.

Ozdemir O, Coskun A, Arikan DC, Kiran G, Guven MA, Kilinc M. To evaluate role of lipid profil in the etiopathogenesis of mild and severe preeclampsia. Prenatal J. 2008;16:75-81.

El-Mazny A, Abou-Salem N, El-Sherbiny W, El-Mazny A. Insulin resistance, dyslipidemia, and metabolic syndrome in women with polycystic ovary syndrome. Int J Gynaecol Obstet. 2010;109:239-41.

Roberts JM. Preeclampsia: What we know and what we do not know. Semin Perinatol. 2000;24:24-28.

Hershkovitz R, de Swiet M, Kingdom J. Mid-trimester placentation assessment in high-risk pregnancies using maternal serum screening and uterine artery Doppler. Hypertens Pregnancy. 2005;24:273-80.

Zhou Y, Damsky CH, Fisher SJ: Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest. 1997;99:2152-64.

Carr DB, McDonald GB, Brateng D, Desai M, Thach CT, Easterling TR. The relationship between hemodynamics and inflammatory activation in women at risk for preeclampsia. Obstet Gynecol. 2001;98:1109-16.

Lim KH, Zhou Y, Janatpour M, McMaster M, Bass K, Chun SH et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol. 1997;151:1809-18.

Bosio PM, McKenna PJ, Conroy R, O'Herlihy C: Maternal central hemodynamics in hypertensive disorders of pregnancy. Obstet Gynecol. 1999;94:978-984.

Danielson LA, Conrad KP: Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. J Clin Invest. 1995;96:482-90.

Vidyabati RK, Davina H, Singh NK, Singh WG. Serum beta hCG and lipid profile in early second trimester as a predictor of pregnancy induced hypertension. J Obstet Gynecol India. 2010;60(1).

JG Ray, P Diamond, P singh G, Bell C. Brief overview of maternal triglycerides as a risk of preeclampsia. Br J Obstet Gynecel. 2006;113(4):379-86.

Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM. Small low density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in pregnancy. Metab Clin Experiment. 1998;47(10):1281-8.

Van Den Elzen HJ, Wladimroff JW, Cohen Overbeek TE, De Vruijn AJ, Grobbee DE. Serum lipids in early pregnancy and risk of Preeclampsia BJOG. 1996;103(2):170-22.

Basu A, Alaupovic P, Wu M, Jenkins AJ, Yu Y, Nankervis AJ et al. Plasma lipoproteins and preeclampsia in women with type 1 diabets: a prospective study. J Clini Endocrinol Metab. March 2012;97(5):1752-62.

Bodnar LM, Ness RB, Markovic N, Roberts JM. The risk of preeclampsia rises with increasing prepregnancy body mass index. Ann Epidemiol. 2005 Aug;15(7):475-82.

Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol. 1997;89(3):403-8.

Lorentzen B, Henriksen T. Plasma lipids and vascular dysfunction in preeclampsia. Semin reprod Endocrinol. 1998;16(1):33-9

Anceschi MM, Coata G, Cosmi EV, Gaiti A, Trovarelli GF, RENZO G. Erythrocyte membrane composition in pregnancy‐induced hypertension: Evidence for an altered lipid profile. BJOG: An Int J Obstet Gynecol. 1992 Jun 1;99(6):503-7.

Murai JT, Muzykanskiy E, Taylor RN. Maternal and fetal modulators of lipid metabolism correlate with the development of preeclampsia. Metabolism. 1997;46:963-7.

Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynaecol. 2001;98:757-62.

Edwards LE, Hellerstedt WL, Alton IR, Story M, Himes JH. Pregnancy complications and birth outcomes in obese and normal weight women: effects of gestational weight change. Obstet Gynecol. 1996;87:389-94.

Steinfeld JD, Valentine S, Lerer T, Ingardia CJ, Wax JR, Curry SL. Obesity-related complications of pregnancy vary by race. J Matern Fetal Med. 2000;9:238-41.

Gifford RW, August PA, Cunningham G. Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1-S22.